About Eolo Pharma
Eolo Pharma is a private company based in Wilmington, Delaware, incorporated in 2019 in Delaware. It has reported $1,799,999 raised in one offering on Form D since February 2023. Its chief executive is Maria Garat.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 7, 2022 | Feb 8, 2023amended Feb 14, 2023 | $1,799,999of $2.9M target | 9 | $199K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Eolo Pharma's Form D filed Feb 14, 2023.
NT
Nicolas Tognalli
Board Member
First appears on the amended Form D that Eolo Pharma filed on February 14, 2023; on 1 of its 2 filings.
CE
Carlos Escande
CSO and Board Member
First appears on the amended Form D that Eolo Pharma filed on February 14, 2023; on 1 of its 2 filings.
PE
Paul Elberse
Board Member
On every Form D that Eolo Pharma has filed: 2 filings, from Feb 8, 2023 to Feb 14, 2023.
MG
Maria Garat
CEO and director
First appears on the amended Form D that Eolo Pharma filed on February 14, 2023; on 1 of its 2 filings.
RH
Roland Haag
Board Member
On every Form D that Eolo Pharma has filed: 2 filings, from Feb 8, 2023 to Feb 14, 2023.
